SG Americas Securities, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$591,000
-62.0%
8,674
-82.2%
0.01%
-58.8%
Q2 2022$1,556,000
+363.1%
48,708
+401.5%
0.02%
+750.0%
Q1 2022$336,000
-55.5%
9,712
-62.3%
0.00%
-50.0%
Q4 2021$755,000
-28.8%
25,786
-38.1%
0.00%
-20.0%
Q3 2021$1,061,000
+53.5%
41,624
+111.1%
0.01%
+66.7%
Q2 2021$691,000
+79.9%
19,719
+109.5%
0.00%
+50.0%
Q1 2021$384,000
-71.3%
9,414
-69.6%
0.00%
-71.4%
Q4 2020$1,340,000
+286.2%
30,943
+392.2%
0.01%
+250.0%
Q3 2020$347,000
+106.5%
6,287
+136.0%
0.00%
+100.0%
Q2 2020$168,000
-78.6%
2,664
-82.7%
0.00%
-85.7%
Q1 2020$786,000
+16.1%
15,384
+80.6%
0.01%
+16.7%
Q4 2019$677,000
+441.6%
8,518
+231.6%
0.01%
+500.0%
Q3 2019$125,000
-51.6%
2,569
-47.2%
0.00%
-50.0%
Q1 2019$258,000
-44.2%
4,869
-56.7%
0.00%
-50.0%
Q4 2018$462,000
+203.9%
11,255
+235.3%
0.00%
+300.0%
Q2 2018$152,000
-11.1%
3,357
-5.0%
0.00%0.0%
Q1 2018$171,000
-8.6%
3,535
-25.6%
0.00%
-50.0%
Q4 2017$187,000
-34.4%
4,753
-48.3%
0.00%
-33.3%
Q3 2017$285,000
+25.6%
9,194
+10.9%
0.00%
+50.0%
Q2 2017$227,000
+44.6%
8,288
+93.9%
0.00%
+100.0%
Q1 2017$157,000
-19.9%
4,274
-68.5%
0.00%
-50.0%
Q4 2016$196,00013,5670.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders